Daniel C. Pevear

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes”.

Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00437

N/A

0DataRank · unranked

47 citations

Allison L. Zulli, Eugen F. Mesaros, Randy W. Jackson, Steven A. Boyd, Bin Liu +13 more

Cefepime–taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018–22

Journal of Antimicrobial Chemotherapy(2024)10.1093/jac/dkae329

N/A

0DataRank · unranked

24 citations

Mark G. Wise, Meredith Hackel, David A. Six, Tsuyoshi Uehara, Denis M. Daigle +4 more

A new class of penicillin-binding protein inhibitors to address drug-resistant Neisseria gonorrhoeae

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.27.630553

N/A

0DataRank · unranked

1 citations

Allison L. Zulli, Brittany Miller, Lindsay M. Avery, Steven A. Boyd, Cassandra L. Chatwin +25 more

Cefepime–taniborbactam and ceftibuten–ledaborbactam maintain activity against KPC variants that lead to ceftazidime–avibactam resistance

Antimicrobial Agents and Chemotherapy(2025)10.1128/aac.01511-24

N/A

0DataRank · unranked

8 citations

Annie Stevenson, Brittany Miller, Denis M. Daigle, Tsuyoshi Uehara, Daniel C. Pevear +1 more